Patents, Price Controls and Access to New Drugs: How Policy Affects Global Market Entry

53 Pages Posted: 31 Mar 2008

See all articles by Jean O. Lanjouw

Jean O. Lanjouw

University of California, Berkeley, College of Natural Resources, Department of Agricultural & Resource Economics (Deceased); Yale University, Faculty of Arts & Sciences, Department of Economics (Deceased); Brookings Institution (Deceased)

Multiple version iconThere are 4 versions of this paper

Date Written: 6/3/2005

Abstract

We consider how patent rights and price regulation affect whether new drugs are marketed in a country, and how quickly. The analysis covers a large sample of 68 countries at all income levels and includes all drug launches over the period 1982-2002. It uses newly compiled information on legal and regulatory policy, and is the first systematic analysis of the determinants of drug launch in poor countries. Price control tends to discourage rapid product entry, while the results for patents are mixed. There is evidence that local capacity to innovate matters and that international pricing externalities may play a role.

Keywords: patent rights, pharmaceuticals, international health

Suggested Citation

Lanjouw, Jean Olson, Patents, Price Controls and Access to New Drugs: How Policy Affects Global Market Entry (6/3/2005). Available at SSRN: https://ssrn.com/abstract=1114163 or http://dx.doi.org/10.2139/ssrn.1114163

Jean Olson Lanjouw (Contact Author)

University of California, Berkeley, College of Natural Resources, Department of Agricultural & Resource Economics (Deceased)

Yale University, Faculty of Arts & Sciences, Department of Economics (Deceased) ( email )

28 Hillhouse Ave
New Haven, CT 06520-8264
United States
203-432-3568 (Phone)
203-432-6323 (Fax)

Brookings Institution (Deceased)

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
57
Abstract Views
484
rank
100,037
PlumX Metrics